chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dry cough; Arm down to his thumb it goes numb not all the time just happen 2 or 3 times a day/Numbness; Hiatal hernia; Arm where the injection went in, it hurt him; tingling; This is a spontaneous report received from a contactable consumer (patient fiancee) via Pfizer sponsored program. A 74-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot Number: EW0150), via an unspecified route of administration, administered in right arm on 02Apr2021 13:00 as dose 2, single for COVID-19 immunization. Medical history and Concomitant medications were not reported. No prior vaccinations (within 4 weeks). Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6199) in right arm on 12Mar2021 01:00 PM for COVID-19 immunization. It was reported that patient after having the second dose now has the dry cough and his arm bothers him and occasionally has numbness in Apr2021. Reporter stated the concern, "Ok, his arm where the injection went in, it hurt him for a while in Apr2021 I don't think it hurt him now, but what happen was he got this straight down the line on his arm down to his thumb it goes numb not all the time just happen 2 or 3 times a day may be and was tingling in Apr2021, but it only come back he was been to ours family physician and he got this dry cough it only happen after the second dose I don't think it happen immediately after and it was not a dry cough, it was not his lung or anything. He had a CAT (Computerised tomogram) scan the other day and that came back negative in Apr2021 except he has a high hiatal hernia in Apr2021 that was it but no cancer nothing else strong and he got this dry cough and I don't know it was associated with the vaccine." Later she says it was not really like a cough but having to clear his throat. He was given amoxicillin the first time he went to the doctor, 125mg on 29Apr2021 for 20 pills, he took them all, once a day. He was given something else next time he went to the doctor, which was 5 to 6 pills but it still didn't go away. Patient visited to Physician Office for adverse events. The outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
2.5 hours after receiving my first dose, I broke out in hives, large slightly raised blotches across my torso and right arm that later spread to my legs.  I took Benadryl 3.5 hours after the shot after an emergency video visit with my doctor.  The hives slowly subsided after taking 3 doses of Benadryl.  24 hours later fatigue and slight chills.
Severe myalgia; severe arthralgia; severe Headache; rigors; extreme fatigue; chest pain; palpitations; tachycardia; Confusion; This is a spontaneous report from a contactable nurse (patient). A 44-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) intramuscular on the right arm on 12Jan2021 13:00 at a single dose for COVID-19 immunization. Medical history included arthritis, B12 deficiency and Allergies: Wasp venom. The patient previously received first dose of BNT162B2 on an 21Dec2020 for COVID-19 immunization (first dose, intramuscular, right arm). Concomitant medication included paracetamol (TYLENOL) and cyanocobalamin (B 12). On 12Jan2021 19:00 PM, the patient experienced severe myalgia, severe arthralgia, severe Headache, rigors, extreme fatigue, chest pain, palpitations, tachycardia. Confusion. Fatigue began approx 6 hours post injection. Other symptoms culminated at around 12 hours post injection. Severe symptoms lasted approx 24 hrs with moderate symptoms following for another 48 hours, followed by mild symptoms for another 12 hours. No treatment was received for the events. Events were reported as non-serious: did not result in death, not life-threatening, did not caused/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. The facility where the vaccine was administered was in a hospital. Patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Outcome of the events was recovered on an unspecified date.   Information on the lot/batch number has been requested.
I've had Tinnitus for several years, but only a mild case. Since receiving the 1st vaccine it has gotten increasingly worse
nerve pain; more than 42 days for administration of second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of NEURALGIA (nerve pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than 42 days for administration of second dose) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939909 and 004F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than 42 days for administration of second dose). On an unknown date, the patient experienced NEURALGIA (nerve pain). At the time of the report, NEURALGIA (nerve pain) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (more than 42 days for administration of second dose) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. It was reported that a patient mentioned having side effects after the second Moderna shot. Treatment medication was not reported.
Headache, Neck swelling, Nausea, Vomiting, : still having these symptoms they started on 04/06/2021
Janssen COVID-19 Vaccine EUA low grade fever-12 hours chills-12 hours body ache-24 hours headache-24 hours shortness of breath-10 hours runny/stuffed nose-10 hours loss of appetite-24 hours fatigue-24 hours upset stomach-randomly
Chicken pox illness (varicella infection) with fever, headache and rash with at least 100 lesions
my health deteriorated; my life is totally upside down/I am not even able to drive the car; I had anxiety; I had got you know heart my heart beat went up so high; I got a panic attack; my confidence has been lost; I feel helpless and you know handicapped; This is a spontaneous report from a contactable consumer or other non hcp (patient).A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: number was not reported) via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunization and received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: number was not reported) via an unspecified route of administration on an unspecified date as 2nd dose, single dose for COVID-19 immunization.The patient medical history and concomitant medications were not reported. On an unspecified,Patient stated after getting the first dose of vaccination patient health deteriorated a lot and after taking the second the patient life was totally upside down. The patient had adverse reactions with vaccination. Patient had anxiety, patient had got you know heart patient heart beat went up so high and patient got a panic attack usually patient was a very healthy person. Patient have never experienced such kind of side effects before and it has gone so high that because of this panic attack and patient was not even able to drive the car or patient not the same person. So patient wanted to report about this because you can understand that this is not you know right. Patient wish patient would have known about the side effects patient might have not even taken it. When confirmed whether patient want to report these adverse events and patient want solution for it. Patient stated that of course patient can understand that patient have stayed at home and patient feel helpless and handicapped. Patient couldn't drive. Patient have been driving from past 13 years and patient had to go to emergency and patient life was not the same, patient had lost confidence. So patient was suffering. Consumer was informed about the Pfizer medical information. Outcome of the events was unknown.   Information on the lot/batch number has been requested.
Medication administration vaccine error the Moderna vaccine was given to a 16 year old male first dose.
I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 on 08/16/2022. I had a runny nose, congested and just felt bad. I contacted my doctor, and I got a prescription Paxlovid. I tolerated the medication without any complications. As of today, I do not have any lingering symptoms of COVID-19.
Brain fog: difficulty thinking, difficulty focusing, impaired short and long term memory, mood swings. I have been trying to wake at the same time everyday, eating healthily, and getting cardiovascular exercise.  Nothing has made it worse or better.
Client, age 17, received Moderna vaccine, which is for age 18+ Per recommendation from CDC she returned 3/11/2021 and had her second Moderna vaccine. No ill effects reported.
Erythema and induration 20cm area around DTaP injection site. Erythema and pruritis entire L upper arm, low chest, back approx. 45cm diameter.
Bells Palsy; This spontaneous case was reported by a patient and describes the occurrence of BELL'S PALSY (Bells Palsy) in a  patient of an unknown age and gender who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On 20-May-2023, the patient experienced BELL'S PALSY (Bells Palsy) (seriousness criterion medically significant). At the time of the report, BELL'S PALSY (Bells Palsy) was resolving.        The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown.   For SPIKEVAX NOS (SPIKEVAX NOS) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Months after covid shot on 20-May-2023 patient was presented with Bell's Palsy. For past 3 months patient was recovering from Bell's Palsy. Treatment medication was not reported. Company Comment: This is a spontaneous case concerning a patient of an unknown age and gender with no reported medical history, who experienced the serious (due to medically significant) expected, AESI event of Bell's palsy, which occurred with unknown exact latency after a dose of Spikevax NOS (unknown COVID-19 vaccination schedule). The outcome of the event was reported as recovering. It was reported that months after covid shot, patient had Bell's Palsy. Patient was recovering from Bell's Palsy during approximately 3 months. The benefit-risk relationship of Spikevax NOS vaccine is not affected by this report.
numbness around nose/mouth approx. 30 minutes after receipt of injection. Dissipated approx. 60 minutes after receipt of injection. Approx. 20 hours after injection, nausea, fever (reaching as high as 100.5 degrees),  chills and mild body aches lasting until approx. 28 hours after injection. Symptoms were too mild to seek medical attention. Treated with Tylenol.
This spontaneous report as received from a licensed practical nurse refers to a 8 year old male patient who on 05-AUG-2009, was vaccinated with the first dose of GARDASIL and on 31-JUL-2013, was vaccinated with the second dose of GARDASIL (doses, routes and lot numbers not reported). No adverse events were reported. Additional information is not expected.
No additional AEs; Caller reported vaccine administered after temperature excursions.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 04-AUG-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 milliliter, lot #X006983, expiration date: 07-MAR-2025, administered intramuscularly for prophylaxis (strength was not provided). This vaccine underwent temperature excursion before adminisration in 18.3 degree Farenheit (F) for 1 hour 5 minutes. No aditional adverse events were reported.
Subsequent to receiving the first dose of Engerix B, the pt experienced agitation and an elevated serum ammonia level - there is no baseline for this pt.  As of 08/24/2000, the outcome of the event is ongoing.
I feel as outer gas; Extreme fatigue; This is a spontaneous report from a contactable consumer (patient) via . A 58-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 intramuscular, administered in Arm Left on 11Feb2021 11:00  (at 58 years old) (Batch/Lot Number: EL9264) as DOSE 1, SINGLE for covid-19 immunisation. Patient has no relevant medical history. The patient's concomitant medications were not reported. The patient underwent lab tests and procedures which included blood test: normal on 2021, urine analysis: normal on 2021. Facility where the most recent COVID-19 vaccine was administered: Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extreme fatigue on 12Feb2021 05:00 with outcome of not recovered. Since taking the vaccine have an increased to extreme amount of fatigued by the end of the day. Patient felt as outer gas and just can't so anymore. It is nearly everyday. No treatment given for the event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The adverse event resulted in visit to Doctor or other healthcare professional office. Dose 2 was given on 03Mar2021,intramuscular Left arm; Lot number: EL1686.  No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a female patient in her 60's who on 06-MAR-2007 was inadvertently vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (lot#652551/1112R) instead of a dose of zoster vaccine live (Oka/Merck). The physician reported that product confusion occurred. The physician also reported that she will most likely wait 1 month and revaccinate patient with zoster vaccine live (Oka/Merck) A product quality complaint was involved. Additional information has been requested.
This case was reported by a consumer via sales rep and described the occurrence of shingles in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 2 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follow: The age at vaccination was not reported. The patient reported that, she took SHINGRIX on a Tuesday and later she experienced the shingles.
Ongoing Tingling,numbness in hands and fingers then moved to right side of my face.Ongoing ringing in my ears!
PT STATED THAT SHE NOTICED THAT THE SITE WAS "TENDER TO THE TOUCH" ON 28 MAY 2008.  REDNESS AND SWELLING AT THE SITE WAS NOTICED ON 30 MAY 2008.
Swelling of the eyes and lips at approx 10:25-10:30am Dr. and NP examined the patient immediately once pt came back into the office Patient was given 6 ml of Benadryl (orally) @ 10:46am and 6 mg of Decadron (intramuscularly) @ 10:55am.
Weakness, tingling, requiring hospitalization and IV gammaglobulin , severe headache from gammaglobulin, transfer hospital, Final diagnosis Guiallian Barret syndrome.  04/02/2007 MR received from a 6 day hospital admission for worsening progressive weakening and paresthesias. Seen twice prior on 2/28/07 and 3/1/07, but discharged home. PE WNL except 4/5 motor strength. 1+elbow and wrist reflexes. 2+ankle reflexes. Weakness noted, especially getting out of a chair. Fatigued appearance.  Slightly wide-based gait. Tx'd with IVIG.  Increasing problems with blurry vision, weakness, SOB, and pelvic muscle difficulty during hospitalization. Transfered to another facility for further care.  Awaiting those records. Primary Discharge DX: 1) Paresthesias with weakness.  Probable Guillain-Barre Syndrome.  2) Chest Pain episode believed 2' to gammaglobulin. (-) CAT scan for PE. 3) Visual Blurriness. Secondary Discharge DX:  1)Increased liver tests 2' to gamma globulin, resolved. 2) Increased D-dimer.  3)Increased CRP.  4)Hypoxia.   04/09/2007 MR received from transferring facility for admission 3/8-12/07 for further evaluation of 1 week of paresthesias, headache and vomiting.  IM and Neuro. evals not entirely c/w GBS (no objective weakness and preserved reflexes). However, repeat EMG was c/w GBS.  DX:  Partially treated Guillian Barre Syndrome.  Status migrainosis vs. chemical meningitis induced by IVIG.
I suffered a mini stroke. [TIA} I had difficulty understanding written words and people speaking to me. it took me a few minutes to realize it was me and not them.
1st Vaccine shot - following day major skin reaction. Itchy patches on hands and legs, turned into large patches of fluid-filled blisters/boils. Horrible pain and itchiness, not able to work, lasted 2 weeks. Went to dermatologist, discovered  a severe case of "eczema herpticum". Strongly suggested no second dose of vaccine following severe allergic reaction. Other reactions on a large scale include: body aches, fatigue, headache, diarrhea, swollen throat and voice loss, low back aches, changes in menstrual cycle.
after 2nd dose, I got tingling a week later/experiencing tingling of her left foot, closer to the little toe and running on the left side of the foot; after 2nd dose, I got numbness a week later/experiencing numbness of her left foot, closer to the little toe and running on the left side of the foot; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (after 2nd dose, I got tingling a week later/experiencing tingling of her left foot, closer to the little toe and running on the left side of the foot) and HYPOAESTHESIA (after 2nd dose, I got numbness a week later/experiencing numbness of her left foot, closer to the little toe and running on the left side of the foot) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy (sulfa medictaions). Concomitant products included MULTIVITAMINS [VITAMINS NOS] and COLECALCIFEROL (VITAMIN D3) for an unknown indication.    On 22-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 29-Sep-2021, the patient experienced PARAESTHESIA (after 2nd dose, I got tingling a week later/experiencing tingling of her left foot, closer to the little toe and running on the left side of the foot) and HYPOAESTHESIA (after 2nd dose, I got numbness a week later/experiencing numbness of her left foot, closer to the little toe and running on the left side of the foot). At the time of the report, PARAESTHESIA (after 2nd dose, I got tingling a week later/experiencing tingling of her left foot, closer to the little toe and running on the left side of the foot) and HYPOAESTHESIA (after 2nd dose, I got numbness a week later/experiencing numbness of her left foot, closer to the little toe and running on the left side of the foot) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2022, Electromyogram: insignificant insignificant.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported that she did not experience numbness and tingling right away with the second  dose. However, she received  those symptoms a week later. She said that the symptoms had been on and off since OCT2021 and she still had them in her left foot. Even while on the call, she was experiencing numbness and tingling of her left foot, closer to the little toe and running on the left side of the foot. No Treatment information was reported.   This case was linked to MOD-2022-507583 (Patient Link).
pt recvd vax 27OCT93 & 29OCT93 devel 2-3 inch area of redness; the next day the arm of inject was completely swollen, & the pt had numbness & tingling down to the finger tips; 31OCT93 took Vicodin w/some relief of swelling & tingling;
Flare of underlying Evans Syndrome, with onset of severe thrombocytopenia occurred 2 weeks and 6 days after the first injection.
This client started scratching his right upper arm at the site of the injection within 5 minutes. An ice pack was applied. Call to the doctor was made. Benadryl was given. At 2:30 PM his BP 136/70, 2:45 PM BP126/80. He had urticaria on his chest arms, and back, with itchiness, a runny nose, no sob or wheezing. Benadryl was given again. Epinephrine was given. The patient was observed for 35 minutes. The rash subsided, and the runny nose stopped. No sob or wheezing. Medrol dose pack given and sent home with the client. Instructed to take Benadryl.
Narrative:  on 3/24/2021 and 4/19/2021 he received both Moderna vaccines in his left arm. On 6/26/2021 he had an unprovoked DVT in the left arm
Menstrual bleeding.  Light. My cycle has been off since first vaccine dose in January 2021.
ErythemaMultiform site red, swollen, warm to touch Narrative:  site red, swollen, warm to touch
Patient was vaccinated at age 17 yrs and 10 months old. The recommended age for this vaccine is 18   No adverse reaction was reported
Adverse reaction to Moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse reaction to Moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse reaction to Moderna vaccine). At the time of the report, VACCINATION COMPLICATION (Adverse reaction to Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 05-Oct-2021: Follow up received contains no new information. On 06-Oct-2021: Follow up received contains no new information.
Pt had typical first 48 hour side effects. Day 8 post injection pt began to have latent side effects including; itchiness at injection site and beyond, redness with heat, swelling at injection site with spreading for 36 hours, headache with no relief after PO OTC's, fatigue, muscle ache not relieved with OTC anti- inflammatory.  Pt reports to staff started on day eight with itchiness and redness in one area, a couple of hours later noticed a second reddened area then lumps by the end of the day. Documentation reported by pt to have swelling at site and near site to be more than a golf ball size below injection site (vs at injection site). Pt reported having latent side effects begin on day eight and continue past day 13 (the time of this report). Pt reports not being able to keep up with housework, children, job duties and school work due to side effects. Pt relied on older daughter (under age 13), and parents to assist so that pt did not miss work.